Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

The Arabidopsis ABCG13 transporter is required for flower cuticle secretion and patterning of the petal epidermis.

Panikashvili D, Shi JX, Schreiber L, Aharoni A.

New Phytol. 2011 Apr;190(1):113-24. doi: 10.1111/j.1469-8137.2010.03608.x. Epub 2011 Jan 14.

2.

The Arabidopsis DSO/ABCG11 transporter affects cutin metabolism in reproductive organs and suberin in roots.

Panikashvili D, Shi JX, Bocobza S, Franke RB, Schreiber L, Aharoni A.

Mol Plant. 2010 May;3(3):563-75. doi: 10.1093/mp/ssp103. Epub 2009 Dec 24.

3.

The Arabidopsis DCR encoding a soluble BAHD acyltransferase is required for cutin polyester formation and seed hydration properties.

Panikashvili D, Shi JX, Schreiber L, Aharoni A.

Plant Physiol. 2009 Dec;151(4):1773-89. doi: 10.1104/pp.109.143388. Epub 2009 Oct 14.

4.

ABC-type transporters and cuticle assembly: Linking function to polarity in epidermis cells.

Panikashvili D, Aharoni A.

Plant Signal Behav. 2008 Oct;3(10):806-9.

5.

The Arabidopsis DESPERADO/AtWBC11 transporter is required for cutin and wax secretion.

Panikashvili D, Savaldi-Goldstein S, Mandel T, Yifhar T, Franke RB, Höfer R, Schreiber L, Chory J, Aharoni A.

Plant Physiol. 2007 Dec;145(4):1345-60. Epub 2007 Oct 19.

6.

The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines.

Panikashvili D, Shein NA, Mechoulam R, Trembovler V, Kohen R, Alexandrovich A, Shohami E.

Neurobiol Dis. 2006 May;22(2):257-64. Epub 2005 Dec 20.

PMID:
16364651
7.

Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury.

Gopez JJ, Yue H, Vasudevan R, Malik AS, Fogelsanger LN, Lewis S, Panikashvili D, Shohami E, Jansen SA, Narayan RK, Strauss KI.

Neurosurgery. 2005 Mar;56(3):590-604.

8.

CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibition.

Panikashvili D, Mechoulam R, Beni SM, Alexandrovich A, Shohami E.

J Cereb Blood Flow Metab. 2005 Apr;25(4):477-84.

PMID:
15729296
9.

Antioxidant properties of the vasoactive endocannabinoid, 2-arachidonoyl glycerol (2-AG).

McCarron RM, Shohami E, Panikashvili D, Chen Y, Golech S, Strasser A, Mechoulam R, Spatz M.

Acta Neurochir Suppl. 2003;86:271-5.

PMID:
14753451
10.

Therapeutic vaccination for closed head injury.

Kipnis J, Nevo U, Panikashvili D, Alexandrovich A, Yoles E, Akselrod S, Shohami E, Schwartz M.

J Neurotrauma. 2003 Jun;20(6):559-69.

PMID:
12906740
11.

Cannabinoids and brain injury: therapeutic implications.

Mechoulam R, Panikashvili D, Shohami E.

Trends Mol Med. 2002 Feb;8(2):58-61.

PMID:
11815270
12.

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury.

Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R, Shohami E.

Nature. 2001 Oct 4;413(6855):527-31.

PMID:
11586361

Supplemental Content

Loading ...
Support Center